Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4+/CD25+/FoxP3+ T ...
Hepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multiple risk...
Background & AimsNeutrophils can either promote or inhibit tumor progression, depending on the tumor...
Aiwu Ruth He,1 Daniel C Smith,1 Lopa Mishra2 1Lombardi Comprehensive Cancer Center, Georgetown Unive...
Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in he...
RATIONALE: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in he...
Hepatocellular carcinomas (HCC) contain a subpopulation of cancer stem cells (CSCs), which exhibit s...
Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are respo...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention a...
Hepatocellular carcinoma (HCC) is a lethal disease with limited treatment options. Immunotherapy is ...
Aging is a major risk factor for progression of liver diseases to hepatocellular carcinoma (HCC). Ce...
Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis, and is one of the leading c...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The cancer ste...
Background/AimsHepatocellular carcinoma (HCC), accounting for 75-85% of primary liver cancer cases, ...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention ...
ObjectivesTo identify key genes involved in vascular invasion in hepatocellular carcinoma (HCC), to ...
Hepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multiple risk...
Background & AimsNeutrophils can either promote or inhibit tumor progression, depending on the tumor...
Aiwu Ruth He,1 Daniel C Smith,1 Lopa Mishra2 1Lombardi Comprehensive Cancer Center, Georgetown Unive...
Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in he...
RATIONALE: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in he...
Hepatocellular carcinomas (HCC) contain a subpopulation of cancer stem cells (CSCs), which exhibit s...
Hepatocellular carcinomas (HCCs) contain a sub-population of cancer stem cells (CSCs) that are respo...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention a...
Hepatocellular carcinoma (HCC) is a lethal disease with limited treatment options. Immunotherapy is ...
Aging is a major risk factor for progression of liver diseases to hepatocellular carcinoma (HCC). Ce...
Hepatocellular carcinoma (HCC) is a malignant tumor with poor prognosis, and is one of the leading c...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death globally. The cancer ste...
Background/AimsHepatocellular carcinoma (HCC), accounting for 75-85% of primary liver cancer cases, ...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Prevention ...
ObjectivesTo identify key genes involved in vascular invasion in hepatocellular carcinoma (HCC), to ...
Hepatocellular carcinoma (HCC) is one of the deadliest cancers. HCC is associated with multiple risk...
Background & AimsNeutrophils can either promote or inhibit tumor progression, depending on the tumor...
Aiwu Ruth He,1 Daniel C Smith,1 Lopa Mishra2 1Lombardi Comprehensive Cancer Center, Georgetown Unive...